Search

everythinglearnresearchcommunity

for

Search:↓

Oral steroids may effectively treat recurrent intussusception in children with ILH, possibly avoiding surgery.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

AR gene not major factor in female hair loss; different from male hair loss.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Finasteride effectively treats BPH and hair loss but may cause sexual side effects.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Spironolactone may help reduce hair loss in androgenic alopecia.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Many women with hard-to-treat acne also have PCOS.

The document concludes that more research is needed to fully understand the causes of PCOS.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.